of human serum. During a one year period, 595 units of blood were obtained from 87 patients with haemochromatosis and polycythaemia, who underwent therapeutic venesection at the Edinburgh and South East Scotland Blood Transfusion Service. Serum from 59% of these donations was used in the EQAS for peptide hormones and related substances. The The suitability of serum from these patients is supported by the observation that in most EQAS the observed all-laboratory consensus mean agrees with the calculated value on adding standard hormone, and that there is a linear correlation between hormone concentration and dilution factor on mixing sera containing high and low concentrations.
Discussion
The key ethical issue in the approach we have described is that pressure to bleed patients to obtain an adequate supply of material may enter into the consideration of whether it is clinically appropriate to perform venesection. We addressed this concern by ensuring that the referring physicians are the trigger to start and stop venesection and that the locally agreed guidelines for venesection are followed rigorously. The patients continue to be super- 
